Cargando…

Use of Prospective Multiplex Immunohistochemistry to Redefine Tissue Pathways of Diagnostic Core Biopsy of Prostate

The incidence of prostatic cancer in the United Kingdom has increased over 40% in the past 30 years. The majority of these cancers are diagnosed by core biopsy, posing a considerable strain on a service that struggles to recruit sufficient histopathologists. The current methodology for tissue diagno...

Descripción completa

Detalles Bibliográficos
Autores principales: Thomas, Teresa, Wedden, Sarah, Afzal, Naveed, Mikel, John, D’Arrigo, Corrado
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9531989/
https://www.ncbi.nlm.nih.gov/pubmed/36083158
http://dx.doi.org/10.1097/PAI.0000000000001033
_version_ 1784802013903585280
author Thomas, Teresa
Wedden, Sarah
Afzal, Naveed
Mikel, John
D’Arrigo, Corrado
author_facet Thomas, Teresa
Wedden, Sarah
Afzal, Naveed
Mikel, John
D’Arrigo, Corrado
author_sort Thomas, Teresa
collection PubMed
description The incidence of prostatic cancer in the United Kingdom has increased over 40% in the past 30 years. The majority of these cancers are diagnosed by core biopsy, posing a considerable strain on a service that struggles to recruit sufficient histopathologists. The current methodology for tissue diagnosis has a significant false-negative rate, small false-positive rate, and a proportion of indeterminate diagnoses. Therefore, this area presents an opportunity both to improve diagnostic quality and to reduce the burden on resources. We investigated streamlining tissue pathways by increasing the utilization of readily available resources to reduce the burden on scarce resources and improve the accuracy of diagnosis. This involved applying prospective multiplex immunohistochemistry (IHC) using 4 different markers (CK5, p63, racemase, and Ki-67) and 2 chromogens. We conducted a prospective study using over 8000 cores and 3 consultant histopathologists. The pathologists assessed each core using either conventional stains (hematoxylin and eosin) only or multiplex IHC only. The results of this assessment were later compared with the overall assessment made for the final histologic diagnosis. Results show that IHC alone has a positive predictive value of 98.97% and a negative predictive value of 99.91%, while hematoxylin and eosin alone has a positive predictive value of 94.21% and negative predictive value of 99.07%, demonstrating improved diagnostic accuracy. When assessed against the use of on-demand IHC, prospective IHC improves turn-around-times, reduces indeterminate diagnoses, improves pathologist’s accuracy and efficiency and, in overall terms, is cost-effective. In addition, it is possible to structure these tests within the routine of a diagnostic service with little impact on the overall capacity of the laboratory.
format Online
Article
Text
id pubmed-9531989
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-95319892022-10-11 Use of Prospective Multiplex Immunohistochemistry to Redefine Tissue Pathways of Diagnostic Core Biopsy of Prostate Thomas, Teresa Wedden, Sarah Afzal, Naveed Mikel, John D’Arrigo, Corrado Appl Immunohistochem Mol Morphol Research Articles The incidence of prostatic cancer in the United Kingdom has increased over 40% in the past 30 years. The majority of these cancers are diagnosed by core biopsy, posing a considerable strain on a service that struggles to recruit sufficient histopathologists. The current methodology for tissue diagnosis has a significant false-negative rate, small false-positive rate, and a proportion of indeterminate diagnoses. Therefore, this area presents an opportunity both to improve diagnostic quality and to reduce the burden on resources. We investigated streamlining tissue pathways by increasing the utilization of readily available resources to reduce the burden on scarce resources and improve the accuracy of diagnosis. This involved applying prospective multiplex immunohistochemistry (IHC) using 4 different markers (CK5, p63, racemase, and Ki-67) and 2 chromogens. We conducted a prospective study using over 8000 cores and 3 consultant histopathologists. The pathologists assessed each core using either conventional stains (hematoxylin and eosin) only or multiplex IHC only. The results of this assessment were later compared with the overall assessment made for the final histologic diagnosis. Results show that IHC alone has a positive predictive value of 98.97% and a negative predictive value of 99.91%, while hematoxylin and eosin alone has a positive predictive value of 94.21% and negative predictive value of 99.07%, demonstrating improved diagnostic accuracy. When assessed against the use of on-demand IHC, prospective IHC improves turn-around-times, reduces indeterminate diagnoses, improves pathologist’s accuracy and efficiency and, in overall terms, is cost-effective. In addition, it is possible to structure these tests within the routine of a diagnostic service with little impact on the overall capacity of the laboratory. Lippincott Williams & Wilkins 2022-10 2022-09-06 /pmc/articles/PMC9531989/ /pubmed/36083158 http://dx.doi.org/10.1097/PAI.0000000000001033 Text en Copyright © 2022 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (https://creativecommons.org/licenses/by-nc-nd/4.0/) (CCBY-NC-ND), where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal. http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/)
spellingShingle Research Articles
Thomas, Teresa
Wedden, Sarah
Afzal, Naveed
Mikel, John
D’Arrigo, Corrado
Use of Prospective Multiplex Immunohistochemistry to Redefine Tissue Pathways of Diagnostic Core Biopsy of Prostate
title Use of Prospective Multiplex Immunohistochemistry to Redefine Tissue Pathways of Diagnostic Core Biopsy of Prostate
title_full Use of Prospective Multiplex Immunohistochemistry to Redefine Tissue Pathways of Diagnostic Core Biopsy of Prostate
title_fullStr Use of Prospective Multiplex Immunohistochemistry to Redefine Tissue Pathways of Diagnostic Core Biopsy of Prostate
title_full_unstemmed Use of Prospective Multiplex Immunohistochemistry to Redefine Tissue Pathways of Diagnostic Core Biopsy of Prostate
title_short Use of Prospective Multiplex Immunohistochemistry to Redefine Tissue Pathways of Diagnostic Core Biopsy of Prostate
title_sort use of prospective multiplex immunohistochemistry to redefine tissue pathways of diagnostic core biopsy of prostate
topic Research Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9531989/
https://www.ncbi.nlm.nih.gov/pubmed/36083158
http://dx.doi.org/10.1097/PAI.0000000000001033
work_keys_str_mv AT thomasteresa useofprospectivemultipleximmunohistochemistrytoredefinetissuepathwaysofdiagnosticcorebiopsyofprostate
AT weddensarah useofprospectivemultipleximmunohistochemistrytoredefinetissuepathwaysofdiagnosticcorebiopsyofprostate
AT afzalnaveed useofprospectivemultipleximmunohistochemistrytoredefinetissuepathwaysofdiagnosticcorebiopsyofprostate
AT mikeljohn useofprospectivemultipleximmunohistochemistrytoredefinetissuepathwaysofdiagnosticcorebiopsyofprostate
AT darrigocorrado useofprospectivemultipleximmunohistochemistrytoredefinetissuepathwaysofdiagnosticcorebiopsyofprostate